Literature DB >> 10072631

Molecular genetics of the human MHC complement gene cluster.

C Y Yu1.   

Abstract

The human major histocompatibility complex (MHC) complement gene cluster (MCGC) is a highly variable region that is characterized by polymorphisms, variations in gene size and gene number, and associations with diseases. Deficiencies in complement C2 are either due to abolition of C2 protein synthesis by mini-deletions that caused frameshift mutations, or blocked secretion of the C2 protein by single amino acid substitutions. One, two or three C4 genes may be present in a human MCGC haplotype and these genes may code for C4A, C4B, or both. Deficiencies of C4A or C4B proteins are attributed to the expression of identical C4 isotypes or allotypes from the C4 loci, the absence or deletion of a C4 gene, 2-bp insertion at exon 29 or 1-bp deletion at exon 20 that caused frameshift mutations. The C4 genes are either 21 or 14.6 kb in size due to the presence of endogenous retrovirus HERV-K(C4) in the intron 9 of long C4 genes. A deletion or duplication of a C4 gene is always accompanied by its neighboring genes, RP at the 5' region, and CYP21 and TNX at the 3' region. These four genes form a genetic unit termed the RCCX module. In an RCCX bimodular structure, the pseudogene CYP21A, and partially duplicated gene segments TNXA and RP2 are present between the two C4 loci. The RCCX modular variations in gene number and gene size contributed to unequal crossovers and exchanges of polymorphic sequences/mutations, resulting in the homogenization of C4 polymorphisms and acquisitions of deleterious mutations in RP1, C4A, C4B, CYP21B and TNXB genes. RD, SKI2W, DOM3Z and RP1 are the four novel genes found between Bf and C4. RD and Ski2w proteins may be related to RNA splicing, RNA turnover and regulation of translation. The functions of Dom3z and RP1 are being investigated. The complete genomic DNA sequence between C2 and TNX is now available. This should facilitate a complete documentation of polymorphisms, mutations and disease associations for the MCGC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10072631     DOI: 10.1159/000019075

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  9 in total

1.  Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region.

Authors:  Michaela Mack; Klaus Bender; Peter M Schneider
Journal:  Immunogenetics       Date:  2004-08-12       Impact factor: 2.846

2.  Complement 4 phenotypes and genotypes in Brazilian patients with classical 21-hydroxylase deficiency.

Authors:  G Guerra-Junior; A Sevciovic Grumach; S H Valente de Lemos-Marini; M Kirschfink; A Condino Neto; M de Araujo; M Palandi De Mello
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

3.  Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.

Authors:  B Selander; H Käyhty; E Wedege; E Holmström; L Truedsson; C Söderström; A G Sjöholm
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

4.  Clathrin heavy and light chain isoforms originated by independent mechanisms of gene duplication during chordate evolution.

Authors:  Diane E Wakeham; Laurent Abi-Rached; Mhairi C Towler; Jeremy D Wilbur; Peter Parham; Frances M Brodsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

5.  Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2.

Authors:  Barbro Selander; Ulla Mårtensson; Andrej Weintraub; Eva Holmström; Misao Matsushita; Steffen Thiel; Jens C Jensenius; Lennart Truedsson; Anders G Sjöholm
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

6.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

7.  Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease.

Authors:  C A Blanchong; B Zhou; K L Rupert; E K Chung; K N Jones; J F Sotos; W B Zipf; R M Rennebohm; C Yung Yu
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

8.  Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.

Authors:  Daisy Rymen; Marco Ritelli; Nicoletta Zoppi; Valeria Cinquina; Cecilia Giunta; Marianne Rohrbach; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-10-25       Impact factor: 4.096

Review 9.  Complement C4, Infections, and Autoimmune Diseases.

Authors:  Hongbin Wang; Mengyao Liu
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.